Improved treatment of neovascularization

Improved treatment of neovascularization

The use of an anti-angiogenic drug selected from inhibitors of protein kinase C, inhibitors of growth hormone and IGF-1 inhibitors of vascular endothelial growth factor, inhibitors of cyclooxygenase II, inhibitors of NF-kappa B, and PLA2 antagonists in conjunction with a photosensitive agent in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: BRAZZELL, ROMULUS KIMBRO
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BRAZZELL, ROMULUS KIMBRO
description The use of an anti-angiogenic drug selected from inhibitors of protein kinase C, inhibitors of growth hormone and IGF-1 inhibitors of vascular endothelial growth factor, inhibitors of cyclooxygenase II, inhibitors of NF-kappa B, and PLA2 antagonists in conjunction with a photosensitive agent in the preparation of a medicament for photodynamic treatment of unwanted neovasculature due to CNV (choroidal neovascularization) in a subject.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ521360A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ521360A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ521360A3</originalsourceid><addsrcrecordid>eNrjZNDwzC0oyi9LTVEoKUpNLMlNzStRyE9TyEvNL0ssTi7NSSzKrEosyczP42FgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8X5RpkaGxmYGjsYEFQAAMbYn6Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Improved treatment of neovascularization</title><source>esp@cenet</source><creator>BRAZZELL, ROMULUS KIMBRO</creator><creatorcontrib>BRAZZELL, ROMULUS KIMBRO</creatorcontrib><description>The use of an anti-angiogenic drug selected from inhibitors of protein kinase C, inhibitors of growth hormone and IGF-1 inhibitors of vascular endothelial growth factor, inhibitors of cyclooxygenase II, inhibitors of NF-kappa B, and PLA2 antagonists in conjunction with a photosensitive agent in the preparation of a medicament for photodynamic treatment of unwanted neovasculature due to CNV (choroidal neovascularization) in a subject.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040730&amp;DB=EPODOC&amp;CC=NZ&amp;NR=521360A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040730&amp;DB=EPODOC&amp;CC=NZ&amp;NR=521360A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BRAZZELL, ROMULUS KIMBRO</creatorcontrib><title>Improved treatment of neovascularization</title><description>The use of an anti-angiogenic drug selected from inhibitors of protein kinase C, inhibitors of growth hormone and IGF-1 inhibitors of vascular endothelial growth factor, inhibitors of cyclooxygenase II, inhibitors of NF-kappa B, and PLA2 antagonists in conjunction with a photosensitive agent in the preparation of a medicament for photodynamic treatment of unwanted neovasculature due to CNV (choroidal neovascularization) in a subject.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDwzC0oyi9LTVEoKUpNLMlNzStRyE9TyEvNL0ssTi7NSSzKrEosyczP42FgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8X5RpkaGxmYGjsYEFQAAMbYn6Q</recordid><startdate>20040730</startdate><enddate>20040730</enddate><creator>BRAZZELL, ROMULUS KIMBRO</creator><scope>EVB</scope></search><sort><creationdate>20040730</creationdate><title>Improved treatment of neovascularization</title><author>BRAZZELL, ROMULUS KIMBRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ521360A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BRAZZELL, ROMULUS KIMBRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BRAZZELL, ROMULUS KIMBRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Improved treatment of neovascularization</title><date>2004-07-30</date><risdate>2004</risdate><abstract>The use of an anti-angiogenic drug selected from inhibitors of protein kinase C, inhibitors of growth hormone and IGF-1 inhibitors of vascular endothelial growth factor, inhibitors of cyclooxygenase II, inhibitors of NF-kappa B, and PLA2 antagonists in conjunction with a photosensitive agent in the preparation of a medicament for photodynamic treatment of unwanted neovasculature due to CNV (choroidal neovascularization) in a subject.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_NZ521360A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Improved treatment of neovascularization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A59%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BRAZZELL,%20ROMULUS%20KIMBRO&rft.date=2004-07-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ521360A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true